The Orifarm Case – How do we do more within Life Science?

The Orifarm Case – How do we do more within Life Science?
This presentation offers a forward-looking perspective on how Orifarm sees the future of Life Science in Europe, with a particular focus on improving access to medicines for patients. It will explore how increasing regulatory complexity, market movements, and supply chain challenges are shaping the industry – and how these dynamics impact the availability and affordability of treatments. The session will highlight opportunities to strengthen a more efficient and resilient European medicines market that ultimately benefits both healthcare systems and patients.